Skip to main content
SpringerLink
Log in

Scintimammography with technetium-99m tetrofosmin in the diagnosis of breast cancer and lymph node metastases

  • Original Article
  • Published:
European Journal of Nuclear Medicine Aims and scope Submit manuscript

Abstract

The aim of the study was to evaluate the possible role of scintimammography (SMM) with technetium-99m tetrofosmin in breast cancer. Thirty-three patients with breast disease and ten normal controls were included in the study. Planar scintigraphic images in supine anterior, prone lateral and lateral views, with the patient lying in lateral recumbency, were acquired. A qualitative analysis evaluating both breasts and lymph nodes was performed. All breast lesions were verified after surgery and/or by fine-needle aspiration. In 8 of the 33 patients, mammography was inconclusive because of mastectomy or dense breasts. For mammography, a sensitivity of 95.6%, a specificity of 66.7% and an accuracy of 89.6% were obtained. At SMM, 26 out of 28 malignant lesions (average size 2.8 cm, range 0.4–12 cm), including two recurrences, were detected with a 92.8% sensitivity, a 100% specificity and a 95.1% accuracy. The smallest detectable carcinoma measured 0.6 cm. Two false-negative results on SMM were found in a 0.4-cm intraductal carcinoma and in the only mucinous papillary carcinoma in our series. With regard to lymph node analysis, 11 out of 12 axillary metastases (sensitivity=91.6%) were detected. A false-positive result, yielding a specificity of 92.3% was also obtained. A metastatic involvement of the internal mammary chain was observed. No uptake was seen in 11 benign mammary lesions or at the level of the breast and axilla when neoplastic involvement was absent. In conclusion, SMM with99mTc-tetrofosmin is an effective technique for the evaluation of primary breast carcinomas, recurrences and lymph node metastases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Harris JR, Hellmann S. Natural history of breast cancer. In: Harris JR, Hellman S, Henderson IC, Kinne DW eds.Breast diseases, 2nd edn. Philadelphia: Lippincott; 1991: 165–181.

    Google Scholar 

  2. Rosen PP. The pathology of invasive breast carcinoma. In: Harris JR, Hellman S, Henderson IC, Kinne DW, eds.Breast diseases, 2nd edn. Philadelphia: Lippincott; 1991: 245–296.

    Google Scholar 

  3. Harris JR, Henderson IC. Staging and prognostic factor. In: Harris JR, Hellman S, Henderson IC, Kinne DW eds.Breast diseases, 2nd edn. Philadelphia: Lippincott; 1991: 327–346.

    Google Scholar 

  4. Burns PE, Grace MG, Lees AW etal. False negative mammograms delay diagnosis of breast cancer.N Engl J Med 1978; 299: 201–202.

    Google Scholar 

  5. Kopans DB. The positive predictive value of mammography.AJR 1992; 158: 521–526.

    PubMed  Google Scholar 

  6. Sickles EA, Mammographic feature of 300 consecutive nonpalpable breast cancers.AJR 1986; 146: 661–663.

    PubMed  Google Scholar 

  7. Mann BD, Giuliano AE, Bassett LW, etal. Delayed diagnosis of breast cancer as a result of normal mammograms.Arch Surg 1983; 118: 23–25.

    PubMed  Google Scholar 

  8. Feig SA, Shaber GA, Patchelskly A. Analysis of clinically occult and mammographically occult breast tumors.AJR 1977; 128: 403–408.

    PubMed  Google Scholar 

  9. Kalisher L. Factors influencing false negative rates in xeromammography.Radiology 1979; 133: 297–301.

    PubMed  Google Scholar 

  10. Fajardo LL, Harvey JA, McAleese KA, Roberts CC, Granstrom P. Breast cancer diagnosis in women with subglandular silicone-gel filed augmentation implants.Radiology 1995; 194: 859–862.

    PubMed  Google Scholar 

  11. Jackson VP, Hendrick RE, Kerg SA, etal. Imaging of the radiographically dense breast.Radiology 1993; 198: 297–301.

    Google Scholar 

  12. Bird RE, Wallace TW Yankaskas BC. Analysis of cancer missed at screening mammography.Radiology 1992; 184: 613–617.

    PubMed  Google Scholar 

  13. Recht A, Sadowsky NL, Cady B. Clinical problems in followup of patients following conservative surgery and radiotherapy.Surg Clin North Am 1990; 70: 1179–1186.

    PubMed  Google Scholar 

  14. Jackson VP. The role of US in breast imaging.Radiology 1990; 177: 305–311.

    PubMed  Google Scholar 

  15. Bassett LW, Kimme-Smith C. Breast ultrasound.AJR 1991; 156: 449–455.

    PubMed  Google Scholar 

  16. Zonderland HM, Hermans J, Holscher HC, Schipper J, Obermann WR. Additional value of US to mammography: profit and loss.Eur Radiol 1994; 4: 511–516.

    Google Scholar 

  17. Kinne DW Kopans DB. Physical examination and mammography in the diagnosis of breast disease. In: Harris JR, Hellman S, Henderson IC, Kinne DW.Breast diseases, 2nd ed. Philadelphia: Lippincott; 1991: pp 81–106.

    Google Scholar 

  18. Harms SE, Flaming DP, Hesley KL, etal. MR imaging of the breast with rotating delivery of excitation of resonance: clinical experience with pathological correlation.Radiology 1993; 187: 493–501.

    PubMed  Google Scholar 

  19. Franceschi D, Crowe J, Zollinger R, etal. Breast biopsy for calcifications in nonpalpable breast lesions.Arch Surg 1990; 125: 170–173.

    PubMed  Google Scholar 

  20. Franceschi D, Crowe J, Lie S, etal. Not all nonpalpable breast cancers are alike.Arch Surg 1991; 126: 967–971.

    PubMed  Google Scholar 

  21. Patel JJ, Gartel PC, Smallwood JA, etal. Fine needle aspiration cytology of breast masses: an evaluation of its accuracy and reasons for diagnostic failure.Ann R Coll Surg Engl 1987; 69: 156–159.

    PubMed  Google Scholar 

  22. Piccolo S, Lastoria S, Mainolfi C, Muto P, Bazzicalupo L, Salvatore M. Technetium-99m-methylene diphosphonate scintimammography to image primary breast cancer.J Nucl Med 1995; 36: 718–724.

    PubMed  Google Scholar 

  23. Waxman AD, Ramanna L, Memsic LD, Foster CE, Silberman AW, Gleischmann SH, Brenner RJ, Brachmann MB, Kuhar CJ, Yadegar J. Thallium scintigraphy in the evaluation of mass abnormalities of the breast.J Nucl Med 1993; 34: 18–23.

    PubMed  Google Scholar 

  24. Cimitan M, Volpe R, Candiani E, Gusso G, Ruffo R, Borsatti E, Massarut S, Rossi C, Morassut S, Carbone A. The use of thallium-201 in the preoperative detection of breast cancer: an adjunct to mammography and ultrasonography.Eur J Nucl Med 1995; 22: 1110–1117.

    PubMed  Google Scholar 

  25. Lee VW, Sax EJ, McAneny DB, Pollack S, Blanchard RA, Beazley RM, Kavanah MT, Ward RJ. A complementary role for thallium-201 scintigraphy with mammography in the diagnosis of breast cancer.J Nucl Med 1993; 34: 2095–2100.

    PubMed  Google Scholar 

  26. Khalkhali I, Cutrone JA, Mena IG, Diggles LE, Venegas RJ, Vargas HI, Jackson BL, Khalkhali S, Moss RF, Klein SR. Scintimammography: the complementary role of Tc-99m sestamibi prone breast imaging for the diagnosis of breast carcinoma.Radiology 1995; 196: 421–426.

    PubMed  Google Scholar 

  27. Scopinaro F, Schillaci O, Scarpini M, Mingazzini PL, Di Macio L, Banci M, Danieli R, Zerilli M, Limiti MR, Centi Colella A. Technetium-99m-sestamibi: an indicator of breast cancer invasiveness.Eur J Nucl Med 1994; 21: 984–987.

    PubMed  Google Scholar 

  28. Burak Z, Argon M, Memis A, Erdem S, Balkan Z, Duman Y, Ustun EE, Erhan Y, Ozkilic H. Evaluation of palpable breast masses with Tc-99m-MIBI: a comparative study with mammography and ultrasonography.Nucl Med Commun 1994; 15: 604–612.

    PubMed  Google Scholar 

  29. Taillefer R, Robidoux A, Lambert R, Turpin S, Laperriere J. Technetium-99m-sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement.J Nucl Med 1995; 36: 1758–1765.

    PubMed  Google Scholar 

  30. Khalkhali I, Cutrone J, Mena I, Diggles L, Venegas R, Vargas H, Jackson B, Klein S. Technetium-99m-sestamibi scintimammography of breast lesions: clinical and pathological followup.J Nucl Med 1995; 36: 1784–1789.

    PubMed  Google Scholar 

  31. Kao CH, Wang SJ, Liu TJ. The use of technetium-99m methoxyisobutylisonitrile breast scintigraphy to evaluate palpable breast masses.Eur J Nucl Med 1994; 21: 432–436.

    PubMed  Google Scholar 

  32. Tiling R, Kress K, Pechmann M, Pfluger T, Kesewitsch P, Tatsch K, Hahn K. Integrated diagnosis of breast turmors: semiquantitative Tc-99m sestamibi imaging versus dynamic MRI.J Nucl Med 1995; 36: 51P.

    Google Scholar 

  33. Palmedo H, Schomburg A, Grünwald F, Bender H, Mallmann P, Biersack HJ. Mammoscintigraphy with Tc-99m MIBI: planar and SPECT imaging techniques in patients with suspicious breast nodules.J Nucl Med 1995; 36: 51P-52P.

    Google Scholar 

  34. Higley B, Smith FW, Smith T, etal. Technetium-99m-1,2bis(2-ethoxyethyl)phosphinoethane: human biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent.J Nucl Med 1993; 34: 30–38.

    PubMed  Google Scholar 

  35. Jones S, Hendel RC. Technetium-99m tetrofosmin: a new myocardial perfusion agent.J Nucl Med Technol 1993; 21: 191–195.

    Google Scholar 

  36. Rambaldi PF, Mansi L, Procaccine E, Di Gregorio F, Del Vecchio E. Breast cancer detection with Tc-99m tetrofosmin.Clin Nucl Med 1995; 20: 703–705.

    PubMed  Google Scholar 

  37. Mansi L, Rambaldi PF, Laprovitera A, Di Gregorio F, Procaccini E. Tc-99m tetrofosmin uptake in breast tumors.J Nucl Med 1995; 36: 83P.

    Google Scholar 

  38. Golia R, Miletto P, Spadafora M, De Rimini ML, De Gennaro S, Mazzarella G, Caracciolo F, Mansi L. An improved technique for mammary scintigraphy in patients with breast cancer.J Nucl Biol Med 1994; 38: 236–237.

    Google Scholar 

  39. Moretti JL, Caglar M, Duran-Cordobes M, Morere JF. Can nuclear medicine predict response to chemotherapy?Eur J Nucl Med 1995; 22: 97–100.

    PubMed  Google Scholar 

  40. Khalkhali I, Mena I, Diggles L. Review of imaging techniques for the diagnosis of breast cancer: a new role of prone scintimammography using technetium-99m sestamibi.Eur J Nucl Med 1994; 21: 357–362.

    PubMed  Google Scholar 

  41. Ell PJ. Keeping abreast of time.Eur J Nucl Med 1995; 22: 967–969.

    PubMed  Google Scholar 

  42. Piccolo S, Lastoria S, Mainolfi C, Wang H, Muto P, Bazzicalupo L, Salvatore M. Primary breast cancer detection by SMM with Tc-99m-MDP: comparison with mammographic and histological result in 400 patients.J Nucl Med 1995; 36: 83P.

    Google Scholar 

  43. Lastoria S, Piccolo S, Varrella P, Acampa W, Mainolfi C, Vergara E, Wang H, Muto P, Salvatore M. Comparative results of Tc-99m MIBI and Tc-99m MDP scintimammography in patients with breast abnormalities.J Nucl Med 1995; 36: 51P.

    Google Scholar 

  44. Ciarmiello A, Del Vecchio S, Potena MI, Mainolfi C, Carriero MV, Tsuruo T, Marone A, Salvatore M. Tc-99m-sestamibi efflux and P-glycoprotein expression in human breast carcinoma.J Nucl Med 1995; 36: 129P

    Google Scholar 

  45. Maublant JC, Zheng Z, Rapp M, etal. In vitro uptake of Tc99m teboroxime in carcinoma cell lines and normal cells: comparison with Tc-99m sestamibi and thallium-201.J Nucl Med 1993; 34: 1949–1952.

    PubMed  Google Scholar 

  46. Adler LP, Crowe JP, Al-Kaisi NK, Sunshine JL. Evaluation of breast masses and axillary lymph nodes with (F-18) 2-deoxy2-fluoro-d-glucose PET.Radiology 1993; 187: 743–750.

    PubMed  Google Scholar 

  47. Pietrzyk U, Scheidhauer K, Scharl A, Schuster A, Schica H. Presurgical visualization of primary breast carcinoma with PET emission and transmission imaging.J Nucl Med 1995; 36: 1882–1884.

    PubMed  Google Scholar 

  48. Dehdashti F, Mortimer JE, Siegel BA, Griffeth LK, Bonasera TJ, Fusselmann MJ, Detert DD, Cutler PD, Katzenellenbogen JA, Welch MJ. Positron tomographic assessment of estrogen receptors in breast cancer: comparison with FDG-PET and in vitro receptor assays.J Nucl Med 1995; 36: 1766–1774.

    PubMed  Google Scholar 

  49. Avril N, Janicke F, Dose J, Bense S, Ziegler S, Zinke M, Laubenbacher C, Romer W, Herz M, Schwaiger M. PET imaging of breast tumors: Miinich experience.J Nucl Med 1995; 36: 82P.

    Google Scholar 

  50. Avril N, Janicke F, Dose J, Bense S, Ziegler S, Zinke M, Römer W, Weber W, Herz M, Schwaiger M. PET evaluation of axillary lymph node involvement in breast cancer patients.J Nucl Med 1995; 36: 82P.

    Google Scholar 

  51. van Eijck CHJ. Krenning EP, Bootsma A, Oei HY, van Pel R, Lindemans J, Jeekel J, Reubi JC, Lamberts SW. Somatostatinreceptor scintigraphy in primary breast cancer.Lancet 1994; 343: 640–643.

    PubMed  Google Scholar 

  52. Taylor JC, Taylor DN, Lowry C, Keeling AA, Bradwell AR, McIntosh A, Rhodes A. Radioimmunoscintigraphy of metastatic breast carcinoma.Eur J Surg Oncol 1992; 18: 57–63.

    PubMed  Google Scholar 

  53. Rijks LIM, de Bruin K, Bakker PJM, Veenhof CHN, Jansenn AGM, van Royen EA. First results with the estrogen receptor radioligand Z-(I-123)MIVE in metastatic breast cancer patients.Eur J Nucl Med 1995; 22: 743.

    Google Scholar 

  54. Pace L, D'Aiuto G, Acampora C, Oliviero P, Botti G, Tatangelo F, Cerra M, Salvatore M. Tumour uptake of 57-cobalt-bleomycin in patients with breast cancer.Eur J Cancer 1993; 29A(2): 195–198.

    PubMed  Google Scholar 

  55. Songadele JA, Younes A, Maublant J, etal. Uptake of Tc-99mtetrofosmin in isolated mitochondria: evidence for an active mechanisms.J Nucl Med 1994; 35: 46P-47P.

    Google Scholar 

  56. Ballinger JR, Banneman J, Boxen I, Firby P, Berry BW Moore MJ, Hartman NG. Accumulation of Tc-99m tetrofosmin in breast tumour cells in vitro: role of multidrug-resistance p-glycoprotein.J Nucl Med 1995; 36: 202P.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Radiological Sciences, School of Medicine, Second University of Naples, Piazza Miraglia 2, I-80138, Napoli, Italy

    Luigi Mansi, Pier Francesco Rambaldi, Fernando Di Gregorio, Biagio Pecori & Walter Del Vecchio

  2. Institute of Experimental Surgery, School of Medicine, Second University of Naples, Italy

    Eugenio Procaccini & Adelina Laprovitera

Authors
  1. Luigi Mansi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pier Francesco Rambaldi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Eugenio Procaccini
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Fernando Di Gregorio
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Adelina Laprovitera
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Biagio Pecori
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Walter Del Vecchio
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mansi, L., Rambaldi, P.F., Procaccini, E. et al. Scintimammography with technetium-99m tetrofosmin in the diagnosis of breast cancer and lymph node metastases. Eur J Nucl Med 23, 932–939 (1996). https://doi.org/10.1007/BF01084367

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01084367

Key words

Search

Navigation